These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D. Brain; 2016 Mar 22; 139(Pt 3):891-907. PubMed ID: 26747862 [Abstract] [Full Text] [Related]
9. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology. Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA, Stark KL, Foreman O, Carano RAD, Friedman BA, Sheng M, Easton A, Bohlen CJ, Hansen DV. Neuron; 2021 Apr 21; 109(8):1283-1301.e6. PubMed ID: 33675684 [Abstract] [Full Text] [Related]
10. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, Shchukina I, Kim MW, Yuede CM, Kipnis J, Artyomov MN, Ulrich JD, Holtzman DM. Nature; 2023 Mar 21; 615(7953):668-677. PubMed ID: 36890231 [Abstract] [Full Text] [Related]
11. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Paasila PJ, Davies DS, Kril JJ, Goldsbury C, Sutherland GT. Brain Pathol; 2019 Nov 21; 29(6):726-740. PubMed ID: 30803086 [Abstract] [Full Text] [Related]
12. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology. Thal DR, Arendt T, Waldmann G, Holzer M, Zedlick D, Rüb U, Schober R. Neurobiol Aging; 1998 Nov 21; 19(6):517-25. PubMed ID: 10192210 [Abstract] [Full Text] [Related]
13. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques. Natunen T, Martiskainen H, Marttinen M, Gabbouj S, Koivisto H, Kemppainen S, Kaipainen S, Takalo M, Svobodová H, Leppänen L, Kemiläinen B, Ryhänen S, Kuulasmaa T, Rahunen E, Juutinen S, Mäkinen P, Miettinen P, Rauramaa T, Pihlajamäki J, Haapasalo A, Leinonen V, Tanila H, Hiltunen M. Mol Neurodegener; 2020 Nov 10; 15(1):66. PubMed ID: 33168021 [Abstract] [Full Text] [Related]
14. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice. Chen Y, Zhao S, Fan Z, Li Z, Zhu Y, Shen T, Li K, Yan Y, Tian J, Liu Z, Zhang B. Alzheimers Res Ther; 2021 Feb 09; 13(1):40. PubMed ID: 33563332 [Abstract] [Full Text] [Related]
15. Increased tauopathy drives microglia-mediated clearance of beta-amyloid. Chen W, Abud EA, Yeung ST, Lakatos A, Nassi T, Wang J, Blum D, Buée L, Poon WW, Blurton-Jones M. Acta Neuropathol Commun; 2016 Jun 23; 4(1):63. PubMed ID: 27339073 [Abstract] [Full Text] [Related]
18. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M, Kuruvilla T, Brooks DJ, Edison P. Brain; 2018 Sep 01; 141(9):2740-2754. PubMed ID: 30052812 [Abstract] [Full Text] [Related]